← Journal search
JOURNAL PROFILE
Download details (PDF) ↓

Recent Advances in Drug Delivery and Formulation (ISSN 2667-3886, 2667-3878) is a journal published by Bentham Science Publishers in the United Arab Emirates. It covers Engineering, Medicine, Pharmacology and Toxicology and Pharmaceutics. It is indexed in Scopus, PubMed and HEC. Recorded metrics: Scopus Q3, CiteScore 2.7 and HEC Y-Category. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, indexing, open access status, aims and scope, about the journal, journal website and registration details from the most reputable indexes, in one place.

Journal title

Recent Advances in Drug Delivery and Formulation

ISSN
2667-3886, 2667-3878
Subject area
EngineeringMedicinePharmacologyToxicology and PharmaceuticsBiomedical EngineeringMedicine (miscellaneous)Pharmaceutical Science
Indexed
ScopusPubMedHEC
Scopus Quartile
Q3
WoS Quartile
—
Impact Factor
—
Country
United Arab Emirates
Publisher
Bentham Science Publishers
SJR
0.36
Open access
No
APC (USD)
—
About the journal
Recent Advances in Drug Delivery and Formulation publishes editorials, mini-reviews, full-length research and review articles, and short technical notes from academia, industry, and regulatory agencies worldwide. The journal’s scope covers topics related to preformulation, formulation development, manufacturing technologies, biopharmaceutics, and regulatory science of both small molecules and biomolecules. These areas include, but are not limited to pharmaceutical nanotechnology, quality by design and process analytical technology, biosimilars and biowaivers, simulation modeling. The journal also publishes guest-edited thematic issues by eminent scientists on current topics that are timely and relevant for both industry and academia. Journal’s ambition is to serve as a means for the dissemination of current fundamental and innovative science including regulatory aspects and stimulate the development of innovative technologies and products for various applications in pharmaceutical sciences and biotechnology.
Aims and Scope
Recent Advances in Drug Delivery and Formulation publishes editorials, mini-reviews, full-length research and review articles, and short technical notes from academia, industry, and regulatory agencies worldwide. The journal’s scope covers topics related to preformulation, formulation development, manufacturing technologies, biopharmaceutics, and regulatory science of both small molecules and biomolecules. These areas include, but are not limited to pharmaceutical nanotechnology, quality by design and process analytical technology, biosimilars and biowaivers, simulation modeling. The journal also publishes guest-edited thematic issues by eminent scientists on current topics that are timely and relevant for both industry and academia. Journal’s ambition is to serve as a means for the dissemination of current fundamental and innovative science including regulatory aspects and stimulate the development of innovative technologies and products for various applications in pharmaceutical sciences and biotechnology.
Journal Website
Journal Website Direct Link ↗
Instructions for Authors URL
—
Scopus URL
Scopus Direct Link ↗
APC Information URL
—
WoS URL
—
SCImago Ranking
15316
HEC
Y-Category
Registered In
2021
Average Time To Publication After Submission (In Weeks)
—
Waiver policy
—
Scopus Cite Score
2.7
WoS Status
—

Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.

Quick answers about Recent Advances in Drug Delivery and Formulation

Is Recent Advances in Drug Delivery and Formulation HEC recognised?

Yes. The catalogue records Recent Advances in Drug Delivery and Formulation in HEC category Y of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.

Is Recent Advances in Drug Delivery and Formulation indexed in Scopus?

Yes. Recent Advances in Drug Delivery and Formulation is listed as Scopus-indexed, in quartile Q3, with a CiteScore of 2.7. Check its current status on the Scopus Sources page.

Is Recent Advances in Drug Delivery and Formulation in Web of Science?

Recent Advances in Drug Delivery and Formulation is not listed as a Web of Science journal in this record. Confirm on Clarivate's Master Journal List.

What is the impact factor of Recent Advances in Drug Delivery and Formulation?

No impact factor is recorded. OpenAlex reports a 2-year mean citedness of 2.37, a similar citation measure based on its own data.

Is Recent Advances in Drug Delivery and Formulation open access, and what does it charge?

Recent Advances in Drug Delivery and Formulation is not recorded as fully open access. Fees change, so check the journal's website before you submit.

Who publishes Recent Advances in Drug Delivery and Formulation?

Recent Advances in Drug Delivery and Formulation is published by Bentham Science Publishers in United Arab Emirates, under ISSN 2667-3886 and 2667-3878.

Research profile

Main research topics: Advanced Drug Delivery Systems, Drug Solubulity and Delivery Systems, Nanoparticle-Based Drug Delivery, Advancements in Transdermal Drug Delivery, Intellectual Property and Patents, Pharmaceutical studies and practices.

Source: OpenAlex (CC0), retrieved 20 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.

Browse similar journals

Find Journal